163 related articles for article (PubMed ID: 30030011)
1. Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes.
Barzilay JI; Davis BR; Ghosh A; Pressel SL; Rahman M; Einhorn PT; Cushman WC; Whelton PK; Wright JT;
J Diabetes Complications; 2018 Sep; 32(9):830-832. PubMed ID: 30030011
[TBL] [Abstract][Full Text] [Related]
2. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
3. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
7. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
9. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
[TBL] [Abstract][Full Text] [Related]
10. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
[TBL] [Abstract][Full Text] [Related]
11. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study.
Nag S; Bilous R; Kelly W; Jones S; Roper N; Connolly V
Diabet Med; 2007 Jan; 24(1):10-7. PubMed ID: 17227319
[TBL] [Abstract][Full Text] [Related]
12. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
13. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
[TBL] [Abstract][Full Text] [Related]
14. All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used?
Fabbian F; De Giorgi A; Monesi M; Pala M; Tiseo R; Misurati E; Parisi C; Volpi R; Graziani R; Mikhailidis DP; Manfredini R
Diab Vasc Dis Res; 2015 Jan; 12(1):46-52. PubMed ID: 25344129
[TBL] [Abstract][Full Text] [Related]
15. Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients.
Bartáková V; Klimešová L; Kianičková K; Dvořáková V; Malúšková D; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Res; 2016; 2016():6726492. PubMed ID: 26824046
[TBL] [Abstract][Full Text] [Related]
16. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
17. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
18. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
[TBL] [Abstract][Full Text] [Related]
20. Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Chen CC; Kung PT; Li CI; Yang SY; Liu CS; Lin WY; Lee CC; Li TC; Kardia SL
Cardiovasc Diabetol; 2012 Oct; 11():131. PubMed ID: 23083001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
